King & Spalding LLP places a particular focus on trademark and competition law matters, with most recent instructions pertaining to contentious pharmaceutical advertising law matters as well as the delimitation of homeopathic products. The team also utilises its combined expertise in pharmaceutical law and trademark disputes to assist with parallel imports in accordance with medical device law, here, practice head Ulf Grundmann is a key contact. Elisabeth Kohoutek (M&A) moved to Luther Rechtsanwaltsgesellschaft mbH in April 2024.
Legal 500 Editorial commentary
Key clients
- CSL Behring GmbH (Deutschland)
- Olin Germany Upstream GmbH & Co. KG
- Novartis Pharma AG
- ratiopharm GmbH
- GlaxoSmithKline Consumer Healthcare GmbH & Co. KG (GSK Consumer Healthcare)
- biomo Group
- Angelini Pharma Deutschland GmbH
- Teva Pharmaceuticals Europe B.V. und Teva GmbH
- Dr. Willmar Schwabe GmbH & Co. KG
- Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG (DHU)
- Roche Diagnostics
- Chemische Fabrik Kreussler Co. GmbH
- DR. KADE Pharmazeutische Fabrik GmbH
- Diagnostic Green
- SGF International e.V.
- Eckes-Granini Group
- Heilerde-Gesellschaft Luvos Just GmbH & Co. KG
- MODJAW SAS
- AgNovos Healthcare
Work highlights
- Representation of Novartis Pharma AG as original manufacturer in the preliminary ruling procedure before the ECJ regarding the parallel import of pharmaceuticals.
- Advising the pharmaceutical manufacturer CSL Behring GmbH in proceedings against parallel importers.
- Advising GSK Consumer Healthcare in a competition dispute regarding advertising claims for the Vitasprint Pro Immun product.